These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20073998)

  • 21. The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients.
    Bader FM; Hagan ME; Crompton JA; Gilbert EM
    J Heart Lung Transplant; 2005 Dec; 24(12):2144-7. PubMed ID: 16364863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive treatment with a dual-acting beta-blocker in the elderly.
    Lessem JN; Weber MA
    J Hypertens Suppl; 1993 Jun; 11(4):S29-36. PubMed ID: 8104239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carvedilol versus cardioselective beta-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus.
    Fardoun RZ
    Pharmacotherapy; 2006 Oct; 26(10):1491-500. PubMed ID: 16999659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of carvedilol on the serum lipid profile.
    Sharp RP; Sirajuddin R; Sharief IM
    Ann Pharmacother; 2008 Apr; 42(4):564-71. PubMed ID: 18364407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
    Abshagen U
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients.
    Jonsson G; Abdelnoor M; Müller C; Kjeldsen SE; Os I; Westheim A
    Cardiology; 2005; 103(3):148-55. PubMed ID: 15785019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined alpha and beta blockers in the therapy of cardiovascular diseases].
    Tavciovski D; Romanović R; Bosković S; Duran P; Matunović R
    Vojnosanit Pregl; 2002; 59(4):405-10. PubMed ID: 12235748
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.
    Jacob S; Rett K; Wicklmayr M; Agrawal B; Augustin HJ; Dietze GJ
    J Hypertens; 1996 Apr; 14(4):489-94. PubMed ID: 8761899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
    Asanuma H; Minamino T; Sanada S; Takashima S; Ogita H; Ogai A; Asakura M; Liao Y; Asano Y; Shintani Y; Kim J; Shinozaki Y; Mori H; Node K; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Jun; 109(22):2773-9. PubMed ID: 15148268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-Blockers in hypertension: is carvedilol different?
    Messerli FH; Grossman E
    Am J Cardiol; 2004 May; 93(9A):7B-12B. PubMed ID: 15144930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta blockers improve outcome in patients with heart failure and atrial fibrillation: U.S. carvedilol study.
    Ramaswamy K
    Card Electrophysiol Rev; 2003 Sep; 7(3):229-32. PubMed ID: 14739719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A risk-benefit assessment of carvedilol in the treatment of cardiovascular disorders.
    Louis WJ; Krum H; Conway EL
    Drug Saf; 1994 Aug; 11(2):86-93. PubMed ID: 7946002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carvedilol: just another Beta-blocker or a powerful cardioprotector?
    Carreira RS; Monteiro P; Gon Alves LM; Providência LA
    Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):257-66. PubMed ID: 17378771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carvedilol for heart failure: more than just a beta-blocker?
    Cleland JG
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using carvedilol to treat heart failure.
    Taccetta-Chapnick M
    Crit Care Nurse; 2002 Apr; 22(2):36-40, 42-6, 48 passim. PubMed ID: 11961943
    [No Abstract]   [Full Text] [Related]  

  • 39. Carvedilol.
    Frishman WH
    Indian Heart J; 1999; 51(3):325-32. PubMed ID: 10624077
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.